Additional information DISCLOSURE/CONFLICT OF INTEREST Michael Berk declares that over the past three years, he has received compensation from Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Norvatis, Mayne Pharma and Servier
Li CY, Liu XC, Li YZ, et al
GHK-Cu gene modulation in fibroblasts
Our research has demonstrated that FOXO4-DRI can improve vascular function by alleviating endothelial cell senescence, providing a novel therapeutic approach for related diseases
Product Images of Kozicare Kojic Acid, Glutathione & Niacinamide Cream Kozicare Kojic Acid, Glutathione & Niacinamide Cream image 1 Kozicare Kojic Acid, Glutathione & Niacinamide Cream image 2 Kozicare Kojic Acid, Glutathione & Niacinamide Cream image 3 Kozicare Kojic Acid, Glutathione & Niacinamide Cream image 4 Kozicare Kojic Acid, Glutathione & Niacinamide Cream image 5 Kozicare Kojic Acid, Glutathione & Niacinamide Cream image 6
& Mardin, B